BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37221653)

  • 1. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
    Vadaparampil ST; Fuzzell LN; Brownstein NC; Fontenot HB; Lake P; Michel A; McIntyre M; Whitmer A; Perkins RB
    Cancer; 2023 Sep; 129(17):2671-2684. PubMed ID: 37221653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Physician Adherence to Guidelines for Cervical Cancer Screening and Management of Abnormal Screening Results.
    Min CJ; Massad LS; Dick R; Powell MA; Kuroki LM
    J Low Genit Tract Dis; 2020 Oct; 24(4):337-342. PubMed ID: 32976292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
    Cox JT;
    Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories.
    Nayar R; Chhieng DC; Crothers B; Darragh TM; Davey DD; Eisenhut C; Goulart R; Huang EC; Tabbara SO
    J Am Soc Cytopathol; 2020; 9(4):291-303. PubMed ID: 32565297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
    Saslow D; Solomon D; Lawson HW; Killackey M; Kulasingam SL; Cain JM; Garcia FA; Moriarty AT; Waxman AG; Wilbur DC; Wentzensen N; Downs LS; Spitzer M; Moscicki AB; Franco EL; Stoler MH; Schiffman M; Castle PE; Myers ER; Chelmow D; Herzig A; Kim JJ; Kinney W; Herschel WL; Waldman J
    J Low Genit Tract Dis; 2012 Jul; 16(3):175-204. PubMed ID: 22418039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Colposcopy: Indications and Risk Assessment.
    Burness JV; Schroeder JM; Warren JB
    Am Fam Physician; 2020 Jul; 102(1):39-48. PubMed ID: 32603071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making Sense of Cervical Cancer Screening Guidelines and Recommendations.
    Davis M; Feldman S
    Curr Treat Options Oncol; 2015 Dec; 16(12):55. PubMed ID: 26467929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007.
    Yabroff KR; Saraiya M; Meissner HI; Haggstrom DA; Wideroff L; Yuan G; Berkowitz Z; Davis WW; Benard VB; Coughlin SS
    Ann Intern Med; 2009 Nov; 151(9):602-11. PubMed ID: 19884621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences among primary care physicians' adherence to 2009 ACOG guidelines for cervical cancer screening.
    Corbelli J; Borrero S; Bonnema R; McNamara M; Kraemer K; Rubio D; Karpov I; McNeil M
    J Womens Health (Larchmt); 2014 May; 23(5):397-403. PubMed ID: 24380500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the indication for colposcopy proposed by the 2019 ASCCP risk-based management consensus guidelines: A single-center study in China.
    Gui T; Chen Z; Chen F
    PLoS One; 2021; 16(7):e0253493. PubMed ID: 34197472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment.
    Fuzzell L; Brownstein NC; Fontenot HB; Lake PW; Michel A; Whitmer A; Rossi SL; McIntyre M; Vadaparampil ST; Perkins RB
    Elife; 2023 Sep; 12():. PubMed ID: 37656169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Papillomavirus Testing by Veterans Administration Women's Health Providers: Are They Adhering to Guidelines?
    Hallett LD; Gerber MR
    J Womens Health (Larchmt); 2018 Feb; 27(2):179-182. PubMed ID: 28885082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards.
    Waxman AG; Conageski C; Silver MI; Tedeschi C; Stier EA; Apgar B; Huh WK; Wentzensen N; Massad LS; Khan MJ; Mayeaux EJ; Einstein MH; Schiffman MH; Guido RS
    J Low Genit Tract Dis; 2017 Oct; 21(4):235-241. PubMed ID: 28953112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colposcopic management of abnormal cervical cytology and histology.
    Bentley J; ;
    J Obstet Gynaecol Can; 2012 Dec; 34(12):1188-1202. PubMed ID: 23231803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice.
    Khan MJ; Werner CL; Darragh TM; Guido RS; Mathews C; Moscicki AB; Mitchell MM; Schiffman M; Wentzensen N; Massad LS; Mayeaux EJ; Waxman AG; Conageski C; Einstein MH; Huh WK
    J Low Genit Tract Dis; 2017 Oct; 21(4):223-229. PubMed ID: 28953110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inadequate Systems to Support Breast and Cervical Cancer Screening in Primary Care Practice.
    Schapira MM; Sprague BL; Klabunde CN; Tosteson AN; Bitton A; Chen JS; Beaber EF; Onega T; MacLean CD; Harris K; Howe K; Pearson L; Feldman S; Brawarsky P; Haas JS;
    J Gen Intern Med; 2016 Oct; 31(10):1148-55. PubMed ID: 27251058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.
    Egemen D; Cheung LC; Chen X; Demarco M; Perkins RB; Kinney W; Poitras N; Befano B; Locke A; Guido RS; Wiser AL; Gage JC; Katki HA; Wentzensen N; Castle PE; Schiffman M; Lorey TS
    J Low Genit Tract Dis; 2020 Apr; 24(2):132-143. PubMed ID: 32243308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
    Munshi VN; Perkins RB; Sy S; Kim JJ
    Am J Obstet Gynecol; 2022 Feb; 226(2):228.e1-228.e9. PubMed ID: 34547295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States.
    Wentzensen N; Massad LS; Mayeaux EJ; Khan MJ; Waxman AG; Einstein MH; Conageski C; Schiffman MH; Gold MA; Apgar BS; Chelmow D; Choma KK; Darragh TM; Gage JC; Garcia FAR; Guido RS; Jeronimo JA; Liu A; Mathews CA; Mitchell MM; Moscicki AB; Novetsky AP; Papasozomenos T; Perkins RB; Silver MI; Smith KM; Stier EA; Tedeschi CA; Werner CL; Huh WK
    J Low Genit Tract Dis; 2017 Oct; 21(4):216-222. PubMed ID: 28953109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
    Perkins RB; Guido RS; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M;
    J Low Genit Tract Dis; 2020 Apr; 24(2):102-131. PubMed ID: 32243307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.